1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Li Peng: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors Icotinib - Vestibular Schwannoma, Neurofibromatosis Type 2 | Phase 2 | Completed | Li Peng | 10 | 2016-07-01 | 2021-09-09 |
Neurofibromatosis 2 (1) · Neuroma, Acoustic (1)
icotinib (1)
China (1)